The Impact of Treatment with Guselkumab on Skin-Related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials

The VOYAGE 1 and 2 trials investigated the impact of guselkumab on skin-related quality of life in patients with moderate to severe psoriasis. The study included both male and female participants and demonstrated that treatment with guselkumab significantly improved the quality of life for these patients. The trials highlighted the effectiveness of guselkumab in managing psoriasis symptoms, leading to better skin health and overall well-being. These findings support the use of guselkumab as a beneficial treatment option for individuals suffering from moderate to severe psoriasis.